ArticleDiabetology international2025
Association of the vaspin gene rs2236242 and chemerin gene rs17173608 variants with type 2 diabetes mellitus in Northeast Iran: a case‒control study.
Article in Diabetology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type 2 diabetes is a complex metabolic disorder caused by a combination of genetic and nongenetic factors. Obesity is one of the main causes of diabetes, and adipose tissue releases different adipokines that regulate glucose and lipid metabolism. Genetic changes in adipokines can reduce their expression or function. The aim of this study was to investigate the associations between the rs2236242 and rs17173608 variants in vaspin and chemerin adipokines and susceptibility to type 2 diabetes and obesity in the northeastern population of Iran. This case‒control study included 200 T2DM patients and 200 healthy controls. After DNA extraction, the vaspin rs2236242 and chemerin rs17173608 gene variants were analyzed via tetra-ARMS-PCR. Genotyping revealed that the TT genotype of the rs2236242 vaspin and the GG and TG genotypes of the rs17173608 chemerin are associated with susceptibility to type 2 diabetes, and there was a strong correlation between a higher risk of type 2 diabetes and the recessive model of TT vs. GG + TG of chemerin. In addition, the TT and TA genotypes of the rs2236242 vaspin in diabetic and normal individuals were significantly associated with overweight and obesity but did not significantly differ between the rs17173608 variant and the BMI. This study demonstrated that the TT genotype of vaspin and the TG and GG genotypes of chemerin may increase the risk of diabetes, and the TT genotype of vaspin is significantly associated with obesity. These results suggest that changing lifestyles might help prevent T2DM in genetically high-risk individuals. Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-025-00836-8.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.